Case Studies
- Date
- December 14, 2016
Related Post Mesothelioma Competitor Landscape Non-Vitamin K Oral Anticoagulants Lucentis Biosimilars- Date
- December 14, 2016
Related Post Mesothelioma Competitor Landscape Non-Vitamin K Oral Anticoagulants Lucentis Biosimilars- Date
- December 14, 2016
Related Post Mesothelioma Competitor Landscape Non-Vitamin K Oral Anticoagulants Oncology Biosimilar Analysis- Date
- December 14, 2016
Our client wanted to introduce a best practice of competitor profiling as part of the product strategy planning exercises. The goal of the project was to perform an in-depth analysis of select Pharmaceutical majors to identify their mindset, goals, strategy and capabilities- Date
- December 17, 2016
Related Post Mesothelioma Competitor Landscape Non-Vitamin K Oral Anticoagulants Lucentis Biosimilars- Date
- December 17, 2016
Related Post Mesothelioma Competitor Landscape Non-Vitamin K Oral Anticoagulants Oncology Biosimilar Analysis- Date
- December 17, 2016
Related Post CI Coverage for Novel Drug Delivery Technologies Market Opportunity Assessment Market Entry Strategy- Date
- December 17, 2016
Related Post CI Coverage for Novel Drug Delivery Technologies Market Opportunity Assessment Technology Landscape & Prioritization- Date
- December 17, 2016
Related Post CI Coverage for Novel Drug Delivery Technologies Market Entry Strategy Technology Landscape & Prioritization- Date
- December 17, 2016
Related Post Market Opportunity Assessment Market Entry Strategy Technology Landscape & Prioritization- Date
- January 9, 2017
Related Post Mesothelioma Competitor Landscape Non-Vitamin K Oral Anticoagulants Lucentis Biosimilars- Date
- February 3, 2017
Related Post Mesothelioma Competitor Landscape Non-Vitamin K Oral Anticoagulants Oncology Biosimilar Analysis- Date
- March 30, 2017
Related Post Mesothelioma Competitor Landscape Oncology Biosimilar Analysis Lucentis Biosimilars- Date
- April 6, 2017
Related Post Non-Vitamin K Oral Anticoagulants Oncology Biosimilar Analysis Lucentis Biosimilars- Date
- April 16, 2019
Related Post Lucentis Biosimilars Clinical Performance Benchmarking Cardiovascular – Beyond The Pill Analysis